Global Conference 2023
Global Conference 2023

The Path to Board Diversity: Moving the Needle from Progress to Maintenance (Invite only)

-

Board compositions are under increasing scrutiny worldwide when it comes to diverse representation. In the context of economic uncertainty and instability, executives are feeling pressure from shareholders to maintain high returns while simultaneously being advocates for social change. Recent years and global challenges have shown that more diverse boards and leadership are strong assets for both immediate and long-term performance, yet marginalized communities remain underrepresented in these roles today, with only 32% of S&P 500 board directors being women and only 22% total from underrepresented racial and ethnic groups, according to Spencer Stuart. Out Leadership found that only 19 Fortune 500 companies explicitly include LGBTQ+ people in their definition of board diversity, resulting in only 26 of those 5,670 board seats—less than 1%—being held by members of the LGBTQ+ community. What is the future of improved board representation for driving social and economic returns as we acknowledge these shortcomings?

    Welcome Remarks

    Image

    Brian
     
    Carandang
     

    Associate Director, Center Advancement, Business and Program Development, Milken Institute

    Moderator

    Image

    Richard
     
    Ditizio
     

    CEO, Milken Institute

    Speaker

    Image

    Kourtney
     
    Gibson
     

    Chief Institutional Client Officer and Senior Executive Vice President, TIAA
    Image

    Ken
     
    Hokugo
     

    Director, Head of Corporate Governance, Pension Fund Association
    Image

    Fabrice
     
    Houdart
     

    Founder and Executive Director, Association of LGBTQ+ Corporate Directors
    Image

    Bahiyah
     
    Robinson
     

    Founder and CEO, VC Include and Include Ventures
    Image

    Geena
     
    Rocero
     

    Author, Producer, Director and Trans Rights Advocate
    Image

    Mark
     
    Weinberger
     

    Director, Johnson & Johnson; MetLife; Saudi Aramco